Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effectiveness of Sugammadex in LMS Surgery
NCT02329964Phase 4Unknown
- Sponsor
- Korea University Anam Hospital
- Start
- Feb 2015
- Primary completion
- Aug 2015
- Modality
- Biodegradable Polymers, Small Molecules
01
Overview
Phase 4, randomised, open-label trial of Sugammadex in neuromuscular blockade (NMB) (2 arms), sponsored by Korea University Anam Hospital. Primary endpoints: Time to Recovery of T1 to 90%, Surgical Rating Score and 2 more. Status: unknown.
02
Drugs
Sugammadex
03
Conditions
neuromuscular blockade (NMB)
Beyond the preview
Go deeper on NCT02329964.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02329964.